Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. - Wikidata - awgldk - TriplyDB

Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.

Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.

http://www.wikidata.org/entity/Q43255574

about

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies Mitochondria as a therapeutic target in heart failure Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress Understanding and preventing mitochondrial oxidative damage Inactivation of pyruvate dehydrogenase kinase 2 by mitochondrial reactive oxygen species A mitochondrial-targeted coenzyme q analog prevents weight gain and ameliorates hepatic dysfunction in high-fat-fed mice Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1 The swan-neck lesion: proximal tubular adaptation to oxidative stress in nephropathic cystinosis.Mitochondria-targeted dodecyltriphenylphosphonium (C12TPP) combats high-fat-diet-induced obesity in mice Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!Mitochondrial oxidative stress and mammalian healthspan.Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis.Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II Neuroprotective strategies involving ROS in Alzheimer disease.Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.The role of mitochondrial DNA mutation on neurodegenerative diseases.Mitochondrial anti-oxidant protects IEX-1 deficient mice from organ damage during endotoxemia.mtDNA Mutagenesis Disrupts Pluripotent Stem Cell Function by Altering Redox Signaling.The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction.Nanotechnology inspired tools for mitochondrial dysfunction related diseases.The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice.Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo.MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle.P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain.Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.Mitochondrial medicine for neurodegenerative diseases.A midlife crisis for the mitochondrial free radical theory of aging.Metabolic effects of a mitochondrial-targeted coenzyme Q analog in high fat fed obese mice.Endothelial mitochondria and heart disease.Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction.Neurodevelopmental manifestations of mitochondrial disease.Polyphenols and human health: a prospectus.Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes.The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.Mitochondrial potassium channels as pharmacological target for cardioprotective drugs.Intracellular redox state as target for anti-influenza therapy: are antioxidants always effective?

P2860

Q21198861-74C22A41-B25F-4C62-BEA9-60B5FA4AFE9F Q27002459-FFE6F070-12AF-47F8-A441-8CB801CFBA2C Q27005632-3FF4DB3D-A172-4C4B-8624-3BEB7C24EB23 Q27025057-D917AB13-6690-4D44-B874-EF8DF547CC84 Q28080331-6EC1ECBF-F57C-4F1F-AA2D-86FC15D233D8 Q28273438-DF305493-D8BB-40CE-B831-AF69580E49E5 Q28383079-F72ED44C-B37E-4A42-8405-A39A559B249D Q28393187-D26D12B1-4E0D-4877-9AF9-A4486DD45AB2 Q28512763-2A9E10CC-5B3C-4F8E-90BE-EDEDBAC1AE7A Q30300701-DFA1E71A-B709-4E05-95C3-EC2616F7D47F Q31122120-E90A25EF-327B-45A1-A64B-1FEBC0DEA8D3 Q33364882-28719753-D15D-4FCB-9379-03177CB428BC Q34104004-A92B3842-5BBF-47AF-8DE0-612C1CDADE33 Q34299931-5796FF77-01D8-426F-9144-174DCC8EE94B Q34536966-2ABC42A3-EC2C-4EFE-AF0C-F904965CE5EB Q34757939-B8F3DD09-4452-4FE5-8B2F-5002870D8EAC Q35148462-2120A305-866A-4DBA-A4A7-EFC63A18949B Q35152954-0A0402B5-E7A6-4BDD-9D1E-4B54BB076F70 Q35382736-613458B6-FAA6-4884-A415-E15A2D25D6FA Q35875121-AAB15581-8AC9-491D-8C03-5A443D573E79 Q35908404-35DAF16B-DFEF-4D7C-84AA-08695F69F472 Q36027388-EB47D68B-8B76-4DD5-ACFC-CDA8BFD31DB3 Q36703351-E67DA795-1C97-42DC-9D8C-B1BF2057A823 Q36879459-81AE60BA-B29E-41F7-9D20-D67CC307B3B5 Q36906640-7AD1FF12-C459-4FD6-8066-8422B52C4A54 Q37315208-97327460-686A-49CD-97CA-0CDF8F508BF5 Q37344846-634CD2E4-170A-46AA-A1E1-BAC646588461 Q37504578-1887F98F-8E6B-4A8B-AF60-D47B8081737A Q37653023-3D0EE394-E8B8-4896-8BC7-34CE7DDB0796 Q37672741-C2217709-8CF8-45BD-BD78-EB19760933F1 Q37688409-1F6F275A-FD91-419C-9D08-786F5C0CDCA7 Q37724298-7EF1CC55-500B-441F-BC3F-D165BD028228 Q37766031-2D3BA7C7-8818-4F84-A894-93B05AA9725E Q37776434-B906DA80-3309-4F87-BA01-3BBEB0F7A5E9 Q37784963-05CA692E-2CAD-43AB-A31D-BBCD1F7A3398 Q37934984-42976B3C-0B56-4B16-8397-40064304518C Q38104693-222D03C3-5213-42B3-AF08-CA5C055EB04D Q38202314-47F8369B-5BDE-4BFC-9D8C-AF6224CD7519 Q38262884-30850AA1-4D1F-4D9C-9C15-EA7B60C1706C Q38283718-51B506CF-E87C-4B9D-9815-1B53EA263CD5

P2860

Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.

http://www.wikidata.org/entity/Q43255574

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Consequences of long-term oral ...... idant MitoQ to wild-type mice.

@en

Consequences of long-term oral ...... idant MitoQ to wild-type mice.

@nl

type

label

Consequences of long-term oral ...... idant MitoQ to wild-type mice.

@en

Consequences of long-term oral ...... idant MitoQ to wild-type mice.

@nl

prefLabel

Consequences of long-term oral ...... idant MitoQ to wild-type mice.

@en

Consequences of long-term oral ...... idant MitoQ to wild-type mice.

@nl

P1433

Q43255574-1D68538B-EBB4-46EB-87C3-6E0883B875E6

P1476

Q43255574-4976B3B4-7E1D-40A2-9653-859E1F86B125

P2093

Q43255574-089765AB-CE46-4741-85B6-E6158ECE0324

Q43255574-1E4EF7A1-11D4-4BB4-BE07-C82A10A355D3

Q43255574-2BFF23E3-E07D-445C-9F39-119217505C70

Q43255574-2D5F9FBC-62DB-4AE1-A5BF-6DFF222B28A6

Q43255574-3097310A-8439-462C-ACC9-22AFCD9B1999

Q43255574-46023D1C-7080-4AF2-8806-124BF4D5C291

Q43255574-51E863FD-207C-4036-B812-A809AF23AC56

Q43255574-529CB10D-58C9-4AA9-AF5B-BE3889C00792

Q43255574-5B56A718-F948-4A11-A1D2-27F0BA10BD81

Q43255574-6E7582C5-F2D3-49C4-ADE1-B6E7652DD39C

P304

Q43255574-7900AE54-F457-4735-BDB2-444B491A443D

P31

Q43255574-DA555664-71D8-4FA5-A6E4-D2E240159AB1

P356

Q43255574-3EA1C33C-8ADD-4A97-BB92-ADAEB8DF6C4F

P433

Q43255574-2FFB324D-BA36-480D-B9AD-8E4FCD97D693

P478

Q43255574-BF2DCD7B-4AD8-4AEC-8D8E-4C03DBA9EEDF

P50

Q43255574-6546FF7D-CE68-4CD7-866D-07648D697D60

Q43255574-9A1DA877-1BE7-487A-AFA5-288AC3917792

Q43255574-A5577117-3FDE-43F3-AEBD-994151CAE74F

Q43255574-CCD16349-BBB2-4732-BDD1-19D6CE8DFDE8

P577

Q43255574-C9C6AD73-50B3-4643-9241-E968BBAF32EA

P5875

Q43255574-11518424-5BE5-4B03-A603-FA5E307F6DE8

P698

Q43255574-8851783A-ED35-4D3B-A543-3D3E87CEE4FE

P921

Q43255574-A48711A6-2BF1-403B-9F86-97839C955793

P356

J.FREERADBIOMED.2009.10.039

P1433

Free Radical Biology and Medicine

P1476

Consequences of long-term oral ...... xidant MitoQ to wild-type mice

@en

P2093

Andrew M James

http://www.w3.org/2001/XMLSchema#string

Angela Logan

http://www.w3.org/2001/XMLSchema#string

Anthony C Smith

http://www.w3.org/2001/XMLSchema#string

Bruce A Jones

http://www.w3.org/2001/XMLSchema#string

Claudia Rose

http://www.w3.org/2001/XMLSchema#string

David C Rubinsztein

http://www.w3.org/2001/XMLSchema#string

Helena M Cochemé

http://www.w3.org/2001/XMLSchema#string

Ian M Fearnley

http://www.w3.org/2001/XMLSchema#string

Ian McFarlane

http://www.w3.org/2001/XMLSchema#string

Irina Abakumova

http://www.w3.org/2001/XMLSchema#string

P304

161-172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FREERADBIOMED.2009.10.039

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. Murphy

Antonio Vidal-Puig

P577

2009-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38033723

http://www.w3.org/2001/XMLSchema#string

P698

19854266

http://www.w3.org/2001/XMLSchema#string

P921